Greetings, ladies and gentlemen, and welcome to SunOpta's Fourth Quarter 2022 Earnings Conference Call. All participants are currently in a listen-only mode; however, a question-and-answer session will follow the prepared remarks. And as a reminder, this conference is being recorded. I would now like to turn the call over to your host, Mr. Reed Anderson with ICR. Please go ahead, sir.

Good afternoon, and thank you for joining us on SunOpta's fourth quarter fiscal 2022 earnings conference call. On the call today are Joe Ennen, Chief Executive Officer; and Scott Huckins, Chief Financial Officer. By now, everyone should have access to the earnings press release that was issued earlier this afternoon and is available on the Investor Relations page on SunOpta's website. This call is being webcast, and its transcription will also be available on the company's website. As a reminder, please note that the prepared remarks which will follow contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. We refer you to all risk factors contained in SunOpta's press release issued this afternoon, the company's annual report filed on Form 10-K, and other filings with the Securities and Exchange Commission for a more detailed discussion of the factors that could cause actual results to differ materially from those projections in any forward-looking statements. The company undertakes no obligation to publicly correct or update the forward-looking statements made during the presentation to reflect future events or circumstances, except as may be required under applicable securities laws. Finally, we would like to remind listeners that the company may refer to certain non-GAAP financial measures during this teleconference. The reconciliation of these non-GAAP financial measures was included with the company's press release issued earlier today. Also, please note that unless otherwise stated, all figures discussed today are in US dollars and are occasionally rounded to the nearest million. I'd like to now turn the call over to Joe.

Good afternoon, and thank you for joining us today. We had another very strong performance in the fourth quarter with revenues in line with guidance, while profitability was significantly above, reflecting solid execution against our key priority of driving strong profitable growth in plant-based and fruit snacks and continuing the optimization of frozen fruit profitability. Please note my prepared remarks will generally exclude the impact of our sunflower business, which was divested at the beginning of the fourth quarter. Let me offer some key takeaways before we begin unpacking the results. Q4 success was achieved much the same way we have driven the business all year, with strong broad-based revenue growth in plant-based from both pricing and real volume growth. Fruit snacks continue to experience incredible growth, and frozen fruit saw continued improvement in profitability linked to better execution. Q4 adjusted EBITDA of $23.5 million was up 123% and was the highest quarter in company history on a normalized basis as we continue to efficiently scale our business and optimize performance across our entire portfolio. In plant-based, revenue growth remains incredibly broad-based. Oat, almond, soy, and coconut all grew double digits, with double-digit increases in retail and over 30% growth in foodservice. We also saw double-digit growth in each of our top three customers. Additionally, all the ways in which we go to market were up double digits, led by our own branded portfolio, which was up 40%. This broad growth is a testament to our competitive advantages and shows we have numerous ways to win with the business model we have built. Our plant-based growth was supported by solid gains in volume in addition to pricing. Customer demand in the quarter was very strong, very steady, and very consistent, and, as I mentioned, very broad-based. We continue to see profit improvements in the fruit segment resulting from the strategies we have talked about extensively. Mix shift to value-added products and network optimization, along with better execution, are delivering results with fruit segment gross profit up 95%. We continue to recover almost all inflationary costs with customer pricing adjustments. We continue to deliver outstanding customer service with case fill rates in plant-based over 98% and fruit-based over 97%. We continue to make gains in business development as our value proposition and competitive advantages continue to attract new customers as well as grow with existing customers. We continue to execute on our capital expansion plans with our 285,000-square-foot greenfield plant in Texas now in operation. We went from first bulldozer to first production in less than 16 months. Lastly, solid execution in 2022 has created durable momentum for the business, and we are well-positioned for another strong year in 2023. Now, I'll turn to our segment results, starting with plant-based, where we remain focused on three strategic priorities. Number one, strengthening and fortifying our competitive advantages; number two, winning in oatmeal; and number three, building a balanced multipronged go-to-market business that includes co-manufacturing, private label, and owned brands. Plant-based revenues were up 23% in the fourth quarter to $136 million, with growth split approximately 60/40 between pricing and volume, with both factors up double digits. These results once again underscore the competitive strength of our platform and why we are frequently a partner of choice. We employ our customers across the full spectrum of channels and categories with industry-leading capabilities and innovation, providing multiple pathways for driving profitable, sustainable growth. Within the segment, core plant-based milk revenue increased 22% and accounted for over 60% of the total segment revenue. Our tea business also continued to deliver outstanding results, with the growth rate accelerating further to 57%, driven by strong customer demand. Finally, broth sales grew 10%, a solid recovery from the third quarter, in part driven by promotional efforts at select customers. Focusing on plant-based milks, we continue to see broad strength across the portfolio as four of our five product types experienced double-digit growth rates. Oat continues to be a strong driver of our plant-based growth, and revenue from all oat products was up 37%. Coconut milk was up 30%, reflecting gains in food service; and soy milk was up mid-teens, with almond milk up low double digits. Next, I'll provide some context on the plant-based milk category and its recent performance based on retail scan data. As a reminder, we estimate retail scan data only captures roughly one-third of total shelf-stable plant-based milks, with untracked food service and club representing two-thirds of the volume. We continue to see solid growth in the overall plant-based milk category. In the 13 weeks that coincide with our fourth quarter, total plant-based milk dollars grew 12%, while units declined 4%. Category growth continues to be led by oat milk with dollars growing 23% and units growing 4%. Looking beyond scan channels, our business results would suggest very strong growth in food service and better-than-retail growth in club. Looking at SunOpta's results by customer channel, total retail was up 17%, reflecting strong growth in mass and club, along with further growth from a large command customer. Food service, which includes our biggest customer, had a very strong performance. The channel sales increased 32%, reflecting significant gains in our Dream branded oat milk. Dream Oat Milk and food service helped propel our overall branded business, up 40% in the fourth quarter, making brands our top-performing go-to-market approach. In addition, we continue to see some resurgence in soy milk, led by younger consumers. Our West Life brand of non-GMO soy products was the fastest-growing brand in the shelf-stable category in the last 13 weeks, fueled by product innovation, distribution gains, and consumer interest in the superior protein content and nutrition profile of soy milk. While not a huge base, it shows our ability to work the edges of the category with innovation. Private label was also very strong, up 35%, driven by broth and new distribution. Co-man revenue rose 14%, reflecting pricing and broad-based gains across major customers and channels. As it relates to capacity expansion projects, all six of our projects needed to double capacity are now complete. These projects have been instrumental in fueling our growth. Plant-based segment revenue and gross profit has doubled since 2018, including 40% growth in the last 24 months. Our greenfield plant in Midlothian, Texas was completed on time and on budget, which is an amazing feat given the macro volatility experienced over the past 16 months around the availability of everything from steel to equipment to labor. We've hired over 100 employees, and many of them have been cross-training at our other plants for a month. We are currently manufacturing salable product and expect volumes to ramp steadily over the next six months. Maybe even more exciting is that commissioning is nearing completion on our 330-milliliter protein shake line, and we expect to begin initial production in Q2 as planned. Over the past several months, we posted visits with many of our top current and prospective customers, and their reactions have been overwhelmingly positive. Overall, business development continues to go quite well as we will be onboarding several new customers in 2023, and just as importantly, expanding business with existing customers. These wins were enabled by Texas, both from a capacity standpoint as well as its attractive geographic location for both SunOpta and our customers. Moving on to our fruit-based segment. Recall our three strategic priorities are: one, de-risking the business through geographic diversification, customer pricing programs, and better grower relations; two, becoming the low-cost operator in frozen fruit through automation, footprint reengineering, and aggressive cost takeouts; and three, evolving the portfolio via mix shift and innovation towards more value-added offerings. Fourth quarter results in fruit fully reflect execution of these three strategies. We saw a surge in growth in fruit snacks, partially offset by expected moderation in frozen fruit as we continue to shift the mix. Segment revenues were up over 4%, driven by a 56% increase in fruit snacks. Impressively, nearly 80% of this growth came from volume, reflecting a continuation of the strong consumer demand trends we've seen all year. This core growth is combined with our ability to leverage key innovations and increased capacity across major retail and CPG customers, pointing to a continued bright future for snacks. Importantly, we delivered significant margin expansion across the entire fruit-based portfolio as we captured scale-related efficiencies in fruit snacks and benefited from our reduced manufacturing cost base and portfolio rationalization in frozen fruit. Gross profit dollars in our fruit-based segment nearly doubled in the fourth quarter, and margin improvement followed a similar trajectory. Turning to our ESG initiatives, we made significant progress in the year. We continue to make real progress towards zero waste in our plants. We joined SEDEX to enhance transparency in our supply chain, and we have made significant progress towards sustainable packaging solutions. As we outlined at Investor Day, one of our goals is to be recognized as a sustainability food and beverage company. In 2022, we improved our CDP score to a B-, above the food and beverage industry average of a C. For those not familiar, CDP is a non-profit company that runs a disclosure system for investors, companies, and governments to manage their environmental impacts. Additionally, our most recent sustainability report clearly outlines our multiyear goals and plans for operating the business consistent with our sustainability heritage. In summary, 2022 was a very good year for SunOpta as we significantly expanded capacity, continued to reshape our portfolio, and again delivered significant growth in revenues and profitability. We entered 2023 in a very strong competitive position with numerous tailwinds that will propel our business, further leverage our strong platform to capture additional share, and expand our addressable market. Our outlook for 2023 is largely unchanged from what we first shared with you several quarters ago at our Investor Day in June of 2022. We remain committed to our long-term growth algorithm of annual double-digit plant-based revenue and profit increases and increasing returns on invested capital. Now, I'll turn the call over to Scott to take us through the rest of the financials.

Thank you very much, Joe, and good afternoon everyone. Fourth quarter revenues of $221 million were up 8.4% year-over-year as reported and grew 16%, excluding the divested sunflower business. Plant-based revenue increased 23%, excluding sunflower, with pricing up 1% and volume up a strong 10%. Fruit-based revenues increased 4.5% led by fruit snacks, which grew 56%. Consolidated gross profit increased 56% to $28 million and was up 82% to $33 million, excluding $4.6 million of startup costs for our Texas plant. Consolidated gross margin was up 400 basis points to 12.8% despite the impact of 210 basis points of startup costs and approximately 80 basis points of headwind from the dilutive effect of passing through higher input costs to customers. In plant-based, segment-level gross profit increased 46% to $21 million and was up 78% to $25 million, excluding the impact of startup costs for Texas. Gross margin in plant-based was up 360 basis points to 15% and would have been 330 basis points higher if we exclude startup costs for Texas. Of the increase in gross margin, approximately 120 basis points was due to the sunflower divestiture. The increase in gross margin reflected both volume growth and pricing. In fruit-based, segment-level gross profit rose 95% to $7 million, and gross margin increased 420 basis points to 9%. The improvement in gross margin was driven by lower manufacturing costs and increased pricing in frozen fruit and significant volume growth, price increases, and plant efficiencies in our fruit snack operations. I would like to reiterate that our focus is on increasing EBITDA growth, driven by gross profit expansion. We are pleased to see this flowing through the P&L. Segment operating income was $5.2 million in the fourth quarter compared to a $1.7 million loss last year, mostly reflecting higher gross profit along with a $1.6 million FX gain. Earnings attributable to common shareholders for the fourth quarter was $0.2 million, compared to a loss of $6.8 million in the prior year period. Adjusted EBITDA was $23.5 million, or 123% higher than $10.6 million in the prior year. As a percentage of revenue, adjusted EBITDA more than doubled from 5.2% last year to 10.6% this year. Turning to the balance sheet and cash flow. To start, we are pleased with where we are on the balance sheet, both from a leverage and debt maturity perspective. For context, we have invested over $200 million of growth capital over the last two years as we seek to double our plant-based business. Our core credit facilities are not due until the end of 2025. As of December 31st, 2022, total debt was $308 million, with leverage of 3.7 times at the end of the fourth quarter. As a reminder, our target leverage is two to four times. We continue to expect to be within that range at year-end 2023, with the first half of the year towards the higher end of the range, followed by gradual improvement as we continue ramping the production capacity that came online over the last couple of quarters. From a cash flow perspective, we had a strong fourth quarter, with positive cash flow before and after capital investment. The divestiture of the sunflower business contributed $8 million to the fourth quarter cash flow profile. Cash provided by operating activities during the fourth quarter of 2022 was $27 million, compared to $20 million during the fourth quarter of 2021. Cash used in investing activities was $20 million, compared with $23 million in last year's fourth quarter, primarily reflecting investments in capacity expansion projects, partially offset by proceeds from the recent divestiture of the sunflower business. Let me close with comments on our outlook, recognizing the environment remains fluid. I will provide our guidance for 2023 along with some perspective on other items across the financial statements. From a guidance standpoint, we expect revenue in a range of $1 billion to $1.05 billion, representing 14% to 20% growth, excluding the divested sunflower business. We would expect the majority of that growth to come from volume, with the balance driven by the wraparound of pricing actions taken throughout 2022. As a reminder, 2022 included $58 million of sunflower revenue, including $17 million in Q1 that will not recur in 2023. Please also refer to the commentary on last year's Q1 call for one-time revenue gains in that quarter. From an adjusted EBITDA standpoint, we would expect a range of $97 million to $103 million, which represents 16% to 23% growth. As we think about the pacing of EBITDA in 2023, we would expect a roughly 45/55 split in the first and second half of the year, with the back half benefiting from the ongoing ramp-up of our Texas facility. Let me also cover a few of our other financial statement items as we see them developing in 2023. From a P&L standpoint, we would expect SG&A to be up low double-digit percent, consistent with the outlook shared at Investor Day, driven in part by stock-based compensation expense. Depreciation will be up $7 million to $8 million as capacity expansions begin to depreciate. Interest expense will be up $12 million to $13 million, with roughly half due to rising interest rates on credit facilities and half from interest on the capital leases used to finance expansion projects. Finally, we would expect $10 million to $12 million of startup costs related to our capital expansion projects, with the flow being approximately $6 million in Q1, $3 million in Q2, and $1 million each in Q3 and Q4. As a reminder, startup costs are recorded in cost of goods sold, reducing gross profit and gross margin, and are added back to EBITDA. From a balance sheet and cash flow standpoint, we would expect capital expenditures on the cash flow statement between $35 million and $45 million, assuming no material new growth investments. Free cash flow is expected in a range of $25 million to $35 million, with year-end leverage in the mid-3s. Each of these estimates are consistent with what we laid out at our Investor Day in June of 2022. As we think about the business post-2025, we would expect a financial algorithm for the total company of low double-digit revenue growth, high teens gross margins with low teens adjusted EBITDA margins and capital expenditures of mid-single-digits as a percentage of revenue. As a reminder, we have said for a long time that we need to deliver a 14.5% CAGR in our plant-based business to achieve our 2025 targets and beyond. One final item to mention: we are planning to host an Analyst and Investor Meeting in mid-April at our newly opened Lothian, Texas facility. This event will showcase our new facility, including an overall update on our business along with a plant tour. We intend this to be both an in-person event and a live webcast will also be available. There will be more details to come. Before opening up the call for questions, just a reminder that for competitive reasons, we do not provide detailed commentary regarding customer or SKU level activity. And with that, operator, please open the call for questions.

Thank you. We'll take our first question this afternoon from Brian Holland of Cowen.

Yes. Thank you. Good afternoon. If I could just start with, obviously, really strong performance in the plant-based beverage category. I know that's been a point of some sensitivity among investors who just kind of look at the high-level data and are wondering how that conveys to your business. So, obviously, strong execution here implies continued share incursion. As we go out to 2023, though, and we obviously see at a high level some deceleration. And Joe, I appreciate the color you provided around how that scanner data impacts and what it doesn't catch in your business? It would be helpful if we have a little sense of the extent that you maybe tether your guidance to underlying category forecasts if there's a range of outcomes for the plant-based beverage category in 2023 that you could help us frame that?

Yes, good morning or good afternoon, Brian. So, you're asking about our category forecast as it relates to scan data? No, it doesn't have to be - just at a category level, I mean, do you have an assumption for the plant-based beverage category grows between X and Y in 2023 and then we're going to take this amount of share. I guess I'm just curious what your starting point is for the category because I think that would help people understand the pace of share incursion that you're anticipating and the extent to which you are maybe making some reasonable assumptions for how the underlying category is going to grow. Yes. We have observed growth in tracked channels in the mid-teens over the past several years. If you look back 10 to 15 years, plant-based milks have shown a consistent low double-digit compound annual growth rate. There are no indications of a slowdown in revenue growth for plant-based milks; this trend has persisted for more than a decade. We are also experiencing strong growth in food service, with consumers increasingly opting for plant-based milks in that sector. When oat milk is introduced, it significantly contributes to overall category growth and momentum. In non-tracked retail channels, such as clubs and other outlets, we also see a robust double-digit growth rate. Overall, our performance has notably surpassed category growth over the last four to six quarters, and we expect this trend to continue.

Got it. I appreciate the information there, Joe. Switching topics for a moment, there have been a lot of weather events along the West Coast. Could you provide us with an update? I understand that the fruit business has evolved and is more focused on Mexico, but could you share any insights regarding tree nuts or fruit crops and any effects on your business in 2023?

Hey Brian, it's Scott. Thanks for the question. So, we're in the heart of the Mexico season now. We're seeing good quality availability. We won't be ramping California production until May. At least the scan here reports we have so far suggest a perfectly fine season. There's certainly been some erosion from the severe weather. At the same time, there's been more acres planted. So, I think as we sit here in March, we're not of a view that we're going to see anything better or worse than we would expect.

Got it. Appreciate that. And then last one for me. Obviously, you stuck with the $100 million EBITDA guidance for 2023. I think when you first provided that 12 months ago, on your initial 2022 guide, it would have implied 40% growth with the 18% upside you've delivered in 2022. We're now suggesting that it's closer to 20% growth, and I certainly don't want to - nothing bad to say about 20% EBITDA growth. Having said that though, I'm curious whether there's anything to interpret from sticking with that guidance in light of the over delivery in 2022 or the outperformance in 2022, whether there's something here that we need to be mindful of that maybe has gotten a little bit worse or there's a headwind here that you're factoring in certainly, it's okay, we're being conservative or if we're mindful of the Midlothian ramp. But just want to understand in the context of the outperformance in 2022, sticking with the $100 million, what is to be interpreted from that? Thanks.

Yes. No problem, Brian. I think I'll start with the answer, we center cut 2023 really consistent with what we outlined really going back almost a year's time. I think it's important to remember, and you hit it on the head as you asked your question, that a lot of the growth in 2023 is a function of: one, onboarding new customers; and two, commercializing additional visits for existing customers. And so, to me, that's inherently some level of volatility in how that works and requires cooperation between SunOpta and the customer base. So, I think could things go better? Of course, they could. But I think, as usual, we want to set or cut the estimate.

Hi, everyone. Thank you for taking my questions. My first question is regarding the growth from new and existing customers. I know you've mentioned this before and touched on it at the beginning of the call. Can you provide some insights on the growth you experienced this quarter from new customers and how much of it came from existing customers?

Yes, the beauty of the quarter, Ryan, was a virtual clean sweep across every cut and dimension of the business. So, as I said several times in the prepared remarks, the highlight and the story of the quarter was exceptionally broad-based growth, especially on the plant-based side, new customers, existing customers, almost every single product type, every single channel, every single go-to-market mechanism we have, all saw double-digit growth. So, we saw consistent with our plans and expectations, contribution from new customers. But incredibly importantly, when you can get your big giant existing core customer base growing double-digit, that is just an incredible amplifier to add new business on top of.

Got it. Makes sense. And I know over the past few quarters, inventory at customers has kind of been sporadic. Do you feel like we've now kind of hit a normalized level and they're kind of returning to normal buying patterns?

Yes. One might characterize the quarter as stable. We experienced very consistent and steady order patterns, which made us feel quite positive. In fact, the quarter met our expectations precisely.

Hey, good afternoon. Thanks for taking the questions. My first one is kind of at a high level on competitive dynamics and how you're thinking about that. Through 2023 and into the future, I know there's only so much that you can say with respect to customers or competitors, et cetera. But just as we think about some of the other publicly traded peers in the space evolving their production capabilities, do you think that that impacts you at all with any of your key customers and anything we should be aware of?

Yes, Andrew, what I would say is every business and every industry has competitors, and we do as well. And we are very confident in our competitive advantages in the service model that we provide our customers. And the proof is in the pudding, right? And you look at just our growth rates in EBITDA, our revenue growth rates, our growth by channel, etc., that is the strongest indicator possible that we have real broad and sustainable competitive advantages. And we certainly have competitors. We respect them and monitor them as closely as possible. But we're confident in the playbook we're running. And we're demonstrating that the business model that we have assembled and the customer service and value equation that we offer customers is proving itself in the marketplace to be incredibly valuable.

Okay, great. That makes sense. Also, a question on kind of broadly the margin progression through the year. And in particular, I'm curious, just as you talked about commissioning that 330-milliliter piece of the business and that coming online. Does that have any material impact on just broader comments on the shape of the margin progression through the year, please?

Yes, Andrew. Hi, it's Scott. I think what we're trying to outline in my prepared remarks was exactly that, that all other factors being equal, you would expect to see positive sequential margin development because I tried to lay out each quarter's estimated startup costs, for example, so from a modeling perspective, you'd have a feel for that. And then the second one is I think I laid out the amount of incremental depreciation. So, just conceptually, go back to the basics, we're bringing up Texas, as an example, selling that through, you'd expect positive margin development sequentially through the year.

Okay, great. And then just a last quick one for me. Just as it relates to the strategy around being the low-cost producer in fruit, what's on the agenda for 2023? And anything new that is on the productivity agenda there that we should be mindful of as we see the year play out? Thanks.

Good question. I think 2022 really demonstrated what we're capable of. If you go back in time, we've talked about - we got to send three plants out of six in that frozen business. I think what's happened is you've seen the flow-through to profit from a better absorbed operating business. And then I think the second piece is, I think you'll recall, we resigned a fair amount of SKUs that were lower de minimis margin. So, from a productivity standpoint, I think we're running the business in frozen exactly as we had expected to, and it shows up in the P&L. I would say turning to fruit snacks we're very excited about really the second half of 2023. I think we've mentioned a few times, we've got a large expansion project in that business that we expect to come online in the third quarter. And that's important because that will deliver another material leg of growth.

Hey, thanks very much guys for taking my question and congratulations for getting the Midlothian facility opened so quickly. I wanted to ask about that facility. It sounds like you're going to have production ramping up steadily as the year progresses. Can you give us a sense of relative to how much product you're going to eventually be producing there in Midlothian? How much of that volume is baked into your guidance for this year?

Is the question really about how we're thinking about Texas? Is it affecting guidance? Or did I miss it?

Yes. But I guess more specifically, I mean, it sounds like you're going to be producing a lot less in Q1 and Q2 than you will be by the end of the year when you have the second line coming on? I guess I'm wondering how much more potential is there to come above and beyond what you're going to produce in the year 2023 based on what you'll be producing in terms of a run rate at the end of the year?

Okay. No, I understand you. So, I guess what I would say is we would expect to start to see more material contribution as you inferred in Q2 than Q1, because think of it as you'd have a full quarter of that first line running. And number two, you would expect to see more contribution in Q3 because we've talked about that 330 mL line coming up in Q2. So, it's a bit of a transitional year, but I think the front and center question is, it's the biggest driver of 2024 and 2025 growth.

For sure, the biggest contributor to that growth was Dream oat milk in foodservice. But we also saw a smaller base, so I hesitate to give percentages; I'll just say that we saw really strong growth in the brand as we continue to drive distribution, principally focused on the natural channel. The velocities are exceptionally strong in the natural channel. Reminder, that's an organic product in a category that does not have much in the way of organic product offerings. So, a key point of difference for us. And then I mentioned our relaunch of the West Life brand, formerly known as West Soy. Early days, but we're certainly encouraged, and as I mentioned, fastest-growing brand in the shelf-stable plant-based milk category in the last 13 weeks, behind innovation, distribution expansion, and a focused team driving productivity around our trade spending. So, a lot of great stuff, but just to kind of end where I started, really, the big load is being carried there by the Dream oat milk in foodservice.

Good afternoon everybody.

Hey Jon.

Hey Jon.

Trying to figure out what to ask. Let's see. So, you've seen broad-based growth in plant-based products. As you look to 2023, do you expect this growth to remain broad-based across different product types, channels, and go-to-market strategies? Or is there a tendency towards one or two specific directions that we should be aware of?

No, Jon. I think certainly, of the last couple of quarters, we've seen - I think the first half of the year, it was kind of the all-oat story. I think in the back half of the year, I would say we saw a bit of a return to a lot of sectors doing well. I mean as I mentioned, we saw coconut milk up, almond milk up, soy milk up which is great to see, right, because that is a core competency for us, which is playing not just in a single product category, but actually having an entire portfolio of nine or ten different product types to satisfy the consumer. So, when we look at the consumer trends within the category, I mean, we see broad growth continuing. And the other piece I would add is we're a customer-driven business, and so when we look customer-by-customer and therefore, channel by channel, we have pretty good line of sight to a continuation of broad-based growth.

Okay, that's helpful. For many of us, we've been tracking, I guess, pricing that you've implemented to reflect commodity pressure. Can you help us think through the two things, the wraparound benefit from price in 2023? And whether kind of the current commodity environment as you see it supports kind of price stability for 2023 at this point? Or if you think they'll be moving up further moving up or further moving it down in pricing?

Yes, Jon. I think I tried to outline, I would expect the majority of the growth to be volume-based, the minority of the growth to be the so-called wraparound of the pricing actions, just to give you that one first. I think as you would expect, there's puts and takes. You have examples like packaging is still escalating, labor costs escalating. But I think when we look at the whole, I think we're in a fortunate position. I don't expect or don't see any broad-based price increases from here. So, that's how at least we're thinking about 2023.

Good, good. I'm looking forward to visiting Midlothian in a few weeks. How much of the volume is currently presold? I believe you mentioned it might be over 50%. You also discussed the business development efforts earlier. Has that percentage increased? Regarding the new 330-milliliter line, do you anticipate being able to ramp it up as quickly as line one, which is focused on existing business? I'm curious if there are additional risks or a longer timeframe involved in the ramp-up of this new line since it is a new product and a growth opportunity for you.

Yes, Jon. So, on the business development front, yes, we continue to make progression, and we could certainly summarize that we are more than 50% utilized as we continue to expand existing customers as well as bring on new customers. So business development continues, and we continue to sell out more and more of the facility. You're 100% spot on. We would take a much more conservative approach in terms of the timelines we have built for ramping the protein shake TAM expansion opportunity. Not because we're not confident in it, but we're trying to be humble and recognizing this is a new capability for us, and we want to deliver on customer expectations in terms of our commitments around timing and volume. So the first line was about as vertical of a start-up as I have ever seen or heard of just an incredible team effort from the company across literally every single function in every single plant. I think we had people from every single one of our manufacturing plants across the country helping in Texas, and that's the benefit of a network. But yes, we're taking a bit more of a conservative approach. We hope to beat it, but we absolutely think that's a prudent approach in managing what is a big new customer for us.

Great. One quick one, a follow-up. On the cash flow situation, I think, Scott, you mentioned positive free cash flow in 2023. What are your kind of priorities for the use of that cash, if I heard that right?

Yes. So, what I was trying to outline, Jon, is very consistent with what I had shared back in June at Investor Day. That outlook still stands. I think that we think about capital deployment as having three alternatives. One is do we find ourselves with attractive organic growth investments? I very much think that we will see that. You were asking about the protein shake business; that would be a good example. Number two would be the potential for bolt-on or add-on M&A opportunities in a dislocated environment, which is, I think, what we've got. And then three would be a return of capital or a share repurchase, for example. And I think how we think about those is the relative return profile against them. And to be clear, they're not mutually exclusive, but those would be the three if you like, apertures of what we could do with that cash flow.

Okay. And I'll just close it by saying, Joe, this was a very unerratic call. Congratulations on a great quarter.

Thanks Jon.

Thanks Jon.

Thank you. And gentlemen, it appears we have no further questions this afternoon. Mr. Ennen, I'd like to hand things back to you for any closing comments.

Great. Thank you for your interest in the company. We appreciate your time this evening and look forward to following up and talking with all of you in further depth.

Thank you, Mr. Ennen. Ladies and gentlemen, that will conclude SunOpta's fourth quarter 2022 earnings conference call. Again, I would like to thank you so much for joining us and wish you all a great remainder of your day. Goodbye.